Review



pathway gene sets (biocarta)  (BioCarta)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    BioCarta pathway gene sets (biocarta)
    Pathway Gene Sets (Biocarta), supplied by BioCarta, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/pathway gene sets (biocarta)/product/BioCarta
    Average 90 stars, based on 1 article reviews
    pathway gene sets (biocarta) - by Bioz Stars, 2026-06
    90/100 stars

    Images



    Similar Products

    pathway gene sets (biocarta)  (BioCarta)
    90
    BioCarta pathway gene sets (biocarta)
    Pathway Gene Sets (Biocarta), supplied by BioCarta, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/pathway gene sets (biocarta)/product/BioCarta
    Average 90 stars, based on 1 article reviews
    pathway gene sets (biocarta) - by Bioz Stars, 2026-06
    90/100 stars
    		  Buy from Supplier
    gene sets derived from biocarta pathways  (BioCarta)
    90
    BioCarta gene sets derived from biocarta pathways
    Gene Sets Derived From Biocarta Pathways, supplied by BioCarta, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/gene sets derived from biocarta pathways/product/BioCarta
    Average 90 stars, based on 1 article reviews
    gene sets derived from biocarta pathways - by Bioz Stars, 2026-06
    90/100 stars
    		  Buy from Supplier
    gene set enrichment analysis of biocarta pathways  (BioCarta)
    90
    BioCarta gene set enrichment analysis of biocarta pathways
    Gene Set Enrichment Analysis Of Biocarta Pathways, supplied by BioCarta, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/gene set enrichment analysis of biocarta pathways/product/BioCarta
    Average 90 stars, based on 1 article reviews
    gene set enrichment analysis of biocarta pathways - by Bioz Stars, 2026-06
    90/100 stars
    		  Buy from Supplier
    gene sets from biocarta pathway database c2:cp:biocarta  (BioCarta)
    90
    BioCarta gene sets from biocarta pathway database c2:cp:biocarta
    Gene Sets From Biocarta Pathway Database C2:Cp:Biocarta, supplied by BioCarta, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/gene sets from biocarta pathway database c2:cp:biocarta/product/BioCarta
    Average 90 stars, based on 1 article reviews
    gene sets from biocarta pathway database c2:cp:biocarta - by Bioz Stars, 2026-06
    90/100 stars
    		  Buy from Supplier
    gene set enrichment analysis biocarta signaling pathway signatures  (BioCarta)
    90
    BioCarta gene set enrichment analysis biocarta signaling pathway signatures
    ( A ) Feature availability among the TCGA (orange), WFCCC (purple), and MDACC (blue) cohorts. Feature names are shown at the right. Unavailable features are labeled in gray. ( B ) Pairwise associations among features in the ER module presented in . The yellow box highlights common associations shared by two groups of associations. ( C ) Patient subtyping using the <t>BioCarta</t> <t>signatures</t> (top region) associated with the ER module. These signatures revealed four subtypes: Immune Inert, Neutral, Active, and Responsive. ( D ) Differential treatment responses assessed by Kaplan-Meier survival analysis of the WFCCC cohort, using distant-metastasis-free survival time as the index. Survival curves of the Immune Neutral (top) and Active (bottom) Subtypes under different treatments are presented and labeled with patient numbers and log-rank test p-values. More details are given in the Supplement.
    Gene Set Enrichment Analysis Biocarta Signaling Pathway Signatures, supplied by BioCarta, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/gene set enrichment analysis biocarta signaling pathway signatures/product/BioCarta
    Average 90 stars, based on 1 article reviews
    gene set enrichment analysis biocarta signaling pathway signatures - by Bioz Stars, 2026-06
    90/100 stars
    		  Buy from Supplier
    curated gene sets (canonical pathways, kegg, reactome, biocarta, chemical and genetic perturbations)  (BioCarta)
    90
    BioCarta curated gene sets (canonical pathways, kegg, reactome, biocarta, chemical and genetic perturbations)
    ( A ) Feature availability among the TCGA (orange), WFCCC (purple), and MDACC (blue) cohorts. Feature names are shown at the right. Unavailable features are labeled in gray. ( B ) Pairwise associations among features in the ER module presented in . The yellow box highlights common associations shared by two groups of associations. ( C ) Patient subtyping using the <t>BioCarta</t> <t>signatures</t> (top region) associated with the ER module. These signatures revealed four subtypes: Immune Inert, Neutral, Active, and Responsive. ( D ) Differential treatment responses assessed by Kaplan-Meier survival analysis of the WFCCC cohort, using distant-metastasis-free survival time as the index. Survival curves of the Immune Neutral (top) and Active (bottom) Subtypes under different treatments are presented and labeled with patient numbers and log-rank test p-values. More details are given in the Supplement.
    Curated Gene Sets (Canonical Pathways, Kegg, Reactome, Biocarta, Chemical And Genetic Perturbations), supplied by BioCarta, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/curated gene sets (canonical pathways, kegg, reactome, biocarta, chemical and genetic perturbations)/product/BioCarta
    Average 90 stars, based on 1 article reviews
    curated gene sets (canonical pathways, kegg, reactome, biocarta, chemical and genetic perturbations) - by Bioz Stars, 2026-06
    90/100 stars
    		  Buy from Supplier
    pathway definitions from biocarta gene sets database  (BioCarta)
    90
    BioCarta pathway definitions from biocarta gene sets database
    ( A ) Feature availability among the TCGA (orange), WFCCC (purple), and MDACC (blue) cohorts. Feature names are shown at the right. Unavailable features are labeled in gray. ( B ) Pairwise associations among features in the ER module presented in . The yellow box highlights common associations shared by two groups of associations. ( C ) Patient subtyping using the <t>BioCarta</t> <t>signatures</t> (top region) associated with the ER module. These signatures revealed four subtypes: Immune Inert, Neutral, Active, and Responsive. ( D ) Differential treatment responses assessed by Kaplan-Meier survival analysis of the WFCCC cohort, using distant-metastasis-free survival time as the index. Survival curves of the Immune Neutral (top) and Active (bottom) Subtypes under different treatments are presented and labeled with patient numbers and log-rank test p-values. More details are given in the Supplement.
    Pathway Definitions From Biocarta Gene Sets Database, supplied by BioCarta, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/pathway definitions from biocarta gene sets database/product/BioCarta
    Average 90 stars, based on 1 article reviews
    pathway definitions from biocarta gene sets database - by Bioz Stars, 2026-06
    90/100 stars
    		  Buy from Supplier
    kegg/biocarta pathway gene sets  (BioCarta)
    90
    BioCarta kegg/biocarta pathway gene sets
    ( A ) Feature availability among the TCGA (orange), WFCCC (purple), and MDACC (blue) cohorts. Feature names are shown at the right. Unavailable features are labeled in gray. ( B ) Pairwise associations among features in the ER module presented in . The yellow box highlights common associations shared by two groups of associations. ( C ) Patient subtyping using the <t>BioCarta</t> <t>signatures</t> (top region) associated with the ER module. These signatures revealed four subtypes: Immune Inert, Neutral, Active, and Responsive. ( D ) Differential treatment responses assessed by Kaplan-Meier survival analysis of the WFCCC cohort, using distant-metastasis-free survival time as the index. Survival curves of the Immune Neutral (top) and Active (bottom) Subtypes under different treatments are presented and labeled with patient numbers and log-rank test p-values. More details are given in the Supplement.
    Kegg/Biocarta Pathway Gene Sets, supplied by BioCarta, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/kegg/biocarta pathway gene sets/product/BioCarta
    Average 90 stars, based on 1 article reviews
    kegg/biocarta pathway gene sets - by Bioz Stars, 2026-06
    90/100 stars
    		  Buy from Supplier
    selected gene sets from biocarta pathways  (BioCarta)
    90
    BioCarta selected gene sets from biocarta pathways
    ( A ) Feature availability among the TCGA (orange), WFCCC (purple), and MDACC (blue) cohorts. Feature names are shown at the right. Unavailable features are labeled in gray. ( B ) Pairwise associations among features in the ER module presented in . The yellow box highlights common associations shared by two groups of associations. ( C ) Patient subtyping using the <t>BioCarta</t> <t>signatures</t> (top region) associated with the ER module. These signatures revealed four subtypes: Immune Inert, Neutral, Active, and Responsive. ( D ) Differential treatment responses assessed by Kaplan-Meier survival analysis of the WFCCC cohort, using distant-metastasis-free survival time as the index. Survival curves of the Immune Neutral (top) and Active (bottom) Subtypes under different treatments are presented and labeled with patient numbers and log-rank test p-values. More details are given in the Supplement.
    Selected Gene Sets From Biocarta Pathways, supplied by BioCarta, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/selected gene sets from biocarta pathways/product/BioCarta
    Average 90 stars, based on 1 article reviews
    selected gene sets from biocarta pathways - by Bioz Stars, 2026-06
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    ( A ) Feature availability among the TCGA (orange), WFCCC (purple), and MDACC (blue) cohorts. Feature names are shown at the right. Unavailable features are labeled in gray. ( B ) Pairwise associations among features in the ER module presented in . The yellow box highlights common associations shared by two groups of associations. ( C ) Patient subtyping using the BioCarta signatures (top region) associated with the ER module. These signatures revealed four subtypes: Immune Inert, Neutral, Active, and Responsive. ( D ) Differential treatment responses assessed by Kaplan-Meier survival analysis of the WFCCC cohort, using distant-metastasis-free survival time as the index. Survival curves of the Immune Neutral (top) and Active (bottom) Subtypes under different treatments are presented and labeled with patient numbers and log-rank test p-values. More details are given in the Supplement.

    Journal: Scientific Reports

    Article Title: Relational Network for Knowledge Discovery through Heterogeneous Biomedical and Clinical Features

    doi: 10.1038/srep29915

    Figure Lengend Snippet: ( A ) Feature availability among the TCGA (orange), WFCCC (purple), and MDACC (blue) cohorts. Feature names are shown at the right. Unavailable features are labeled in gray. ( B ) Pairwise associations among features in the ER module presented in . The yellow box highlights common associations shared by two groups of associations. ( C ) Patient subtyping using the BioCarta signatures (top region) associated with the ER module. These signatures revealed four subtypes: Immune Inert, Neutral, Active, and Responsive. ( D ) Differential treatment responses assessed by Kaplan-Meier survival analysis of the WFCCC cohort, using distant-metastasis-free survival time as the index. Survival curves of the Immune Neutral (top) and Active (bottom) Subtypes under different treatments are presented and labeled with patient numbers and log-rank test p-values. More details are given in the Supplement.

    Article Snippet: The underlying mechanisms of the discovered modules were revealed by gene set enrichment analysis using BioCarta signaling pathway signatures .

    Techniques: Labeling